Altis Labs Announces Presentation of AI Model Evaluation on Data from Phase 3 Lung Cancer Trial at ELCC 2025
Altis's AI Model Outperforms RECIST 1.1 in Predicting Overall Survival PARIS, FRANCE, March 26, 2025 /EINPresswire.com/ -- Altis Labs, Inc. (“Altis”) the computational imaging company accelerating clinical trials with AI, today announced the …